KURA
Kura Oncology Inc
NASDAQ: KURA · HEALTHCARE · BIOTECHNOLOGY
$8.83
+0.91% today
Updated 2026-04-30
Market cap
$776.67M
P/E ratio
—
P/S ratio
11.51x
EPS (TTM)
$-3.18
Dividend yield
—
52W range
$5 – $12
Volume
1.5M
Kura Oncology Inc (KURA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $53.88M | $67.48M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +25.2% |
| Cost of revenue | — | $19158.00 | $20509.00 | $23440.00 | $22341.00 | $22734.00 | $23907.00 | $20000.00 | $31000.00 | $30000.00 | $10000.00 | — | $194000.00 | $558000.00 | $759000.00 | $849000.00 | $848000.00 | $57000.00 |
| Gross profit | — | $-19158.00 | $-20509.00 | $-23440.00 | $-22341.00 | $-22734.00 | $-23907.00 | $-20000.00 | $-31000.00 | $-30000.00 | $-10000.00 | — | $-194000.00 | $-558000.00 | $-759000.00 | $-849000.00 | $53.88M | $67.42M |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 100.0% | 99.9% |
| R&D | — | — | — | — | — | — | $8.05M | $17.78M | $20.40M | $26.43M | $46.79M | $47.83M | $60.40M | $84.72M | $92.81M | $115.23M | $169.97M | $251.07M |
| SG&A | — | $19158.00 | $20509.00 | $20509.00 | $23440.00 | $22341.00 | $3.85M | $6.09M | $7.96M | $9.65M | $16.10M | $19.65M | $31.31M | $46.54M | $47.05M | $50.57M | $77.11M | $119.98M |
| Operating income | $-33623.00 | $-38316.00 | $-41018.00 | $-20509.00 | $-23440.00 | $-22341.00 | $-11.80M | $-23.86M | $-28.37M | $-36.08M | $-62.88M | $-67.48M | $-91.90M | $-131.26M | $-139.87M | $-165.80M | $-193.19M | $-303.63M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -358.5% | -449.9% |
| EBITDA | $-33623.00 | $-38316.00 | $-41018.00 | $-20509.00 | $-23440.00 | $-22341.00 | $-11.80M | $-23.84M | $-28.34M | $-36.05M | $-62.87M | $-67.48M | $-88.85M | $-129.49M | $-134.85M | $-150.23M | $-169.50M | $-303.63M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -314.6% | -449.9% |
| EBIT | $-33623.00 | $-38316.00 | $-41018.00 | $-20509.00 | $-23440.00 | $-22341.00 | $-11.80M | $-23.86M | $-28.37M | $-36.08M | $-62.88M | $-67.48M | $-89.05M | $-130.05M | $-135.61M | $-151.08M | $-170.35M | $-304.66M |
| Interest expense | — | $838.00 | $1886.00 | $1886.00 | $3600.00 | $4974.00 | $5877.00 | $88000.00 | $577000.00 | $888000.00 | $970000.00 | $580000.00 | $578000.00 | $414000.00 | $229000.00 | $1.55M | $1.62M | $1.51M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-33623.00 | $-19996.00 | $-22395.00 | $-22395.00 | $-27040.00 | $-27315.00 | $-11.01M | $-22.63M | $-27.56M | $-35.43M | $-60.45M | $-63.14M | $-89.63M | $-130.47M | $-135.84M | $-152.63M | $-173.98M | $-278.67M |
| Net income growth (YoY) | — | +40.5% | -12.0% | +0.0% | -20.7% | -1.0% | -40218.5% | -105.4% | -21.8% | -28.6% | -70.6% | -4.5% | -41.9% | -45.6% | -4.1% | -12.4% | -14.0% | -60.2% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -322.9% | -412.9% |